OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. Aurora, D. Dodick, C. Turkel, R. DeGryse +4 more
2010Cephalalgia918 citations Open access
Semantic Scholar

